Boehringer Ingelheim Animal Health Canada Inc.

Founded in 1885 and with a strong presence in North America, Boehringer Ingelheim is a global animal health leader offering science-backed solutions for swine producers. Their North American swine portfolio includes vaccines and treatments for key diseases like PRRS, ileitis, and Mycoplasma, along with herd health monitoring and diagnostics. Through programs like Area Regional Control and Dynamic Pig Health, they support U.S. and Canadian farmers in improving biosecurity and productivity. Their expert network and research partnerships help producers stay ahead of emerging threats in the pork industry.